{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:40:29Z","timestamp":1788885629334,"version":"build-2803163510"},"reference-count":41,"publisher":"Bentham Science Publishers Ltd.","issue":"8","funder":[{"DOI":"10.13039\/501100001410","name":"Human Resource Development Group (HRDG), India","doi-asserted-by":"publisher","award":["09\/476(0096)\/2019-EMR-1"],"award-info":[{"award-number":["09\/476(0096)\/2019-EMR-1"]}],"id":[{"id":"10.13039\/501100001410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>As the number of new cancer cases increases every year, there is a necessity to develop\nnew drugs for the treatment of different types of cancers. Plants' resources are considered to be huge reservoirs\nfor therapeutic agents in nature. Among all the medicinal plants, Oroxylum indicum is one of the most widely\nused medicinal plants in India, China, and Southeast Asian countries. Combinatorial drug treatment, on the other\nhand, is favored over single drug treatment in order to target multiple biomolecular moieties that help in the\ngrowth and development of cancer. Therefore, combinatorial drug treatment using a co-crystal of multiple drugs\ngives researchers an idea of the development of a new type of drug for targeting multiple targets. In this study, a\nnew co-crystal of chrysin and oroxylin A was isolated from the leaves of O. indicum, and its anticancer properties\nwere studied in cervical cancer cells HeLa.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Aim:<\/jats:title>\n<jats:p>This study was conducted with the aim of identifying new anticancer compounds from the leaves of Oroxylum\nindicum and studying the anticancer properties of the isolated compound.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>In this study, we elucidated the structure of a new co-crystal compound, which was isolated from the\nleaf extract of Oroxylum indicum. The apoptosis induction mechanism of the newly discovered co-crystal in\nHeLa cells was also studied.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A crystal compound from the chloroform extract of leaves of Oroxylum Indicum was isolated by solvent\nfractionation and chromatographic methods involving HPLC. The molecular structure of the isolated crystal\nwas elucidated by Single Crystal-XRD, FT-IR analysis, and further determined by LC-MS. The antiproliferative\nactivity was carried out using an MTT assay and fluorescence microscopy, and the mechanism of apoptosis was\ndetermined using Western blotting techniques.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The novel co-crystal consists of two active pharmaceutical ingredients (APIs) in a 1:1 ratio, i.e., oroxylin\nA and chrysin. The isolated new co-crystal induced death in HeLa cells with a very low IC50 value of 8.49 \u03bcM. It\ninduced caspase-dependent apoptosis in HeLa cells by activation of Caspase-3 through inhibition of ERKs and\nactivation of p38 of MAPK cell signalling pathway.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>This study presents the first report on the discovery of a naturally occurring co-crystal of chrysin and\noroxylin A and the involvement of ERKs and p38 of MAPK pathways in the induction of apoptosis in HeLa cells\nby the co-crystal. Our study sheds light on the development of a co-crystal of chrysin and oroxylin A in a specific\nratio of 1:1 for combination therapy of the two APIs. The purified co-crystal was found to be more efficient compared\nto the compounds present individually. Further analysis of the physiochemical properties and molecular\nmechanisms of the isolated co-crystal in different cancer cells is warranted for its application in therapeutics.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0118715206364530241128044041","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T11:41:04Z","timestamp":1734349264000},"page":"563-573","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Discovery of a Novel Co-crystal of Chrysin and Oroxylin A with Anticancer Properties from Leaves of <i>Oroxylum indicum<\/i>"],"prefix":"10.2174","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5787-5744","authenticated-orcid":true,"given":"Salam Asbin","family":"Singh","sequence":"first","affiliation":[{"name":"Department of Biotechnology, Manipur University, Canchipur, Manipur, 795003, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1235-3738","authenticated-orcid":true,"given":"Asem Robinson","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Manipur University, Canchipur, Manipur, 795003, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atom Rajiv","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Manipur University, Canchipur, Manipur, 795003, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoubam Sujita","family":"Devi","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Manipur University, Canchipur, Manipur, 795003, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhaz","family":"Korimayum","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Manipur University, Canchipur, Manipur, 795003, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisam Shanjukumar","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Manipur University, Canchipur, Manipur, 795003, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33588","author":"Ferlay J.","year":"2020","unstructured":"Ferlay J.;  Global Cancer Observatory: Cancer Today  2020","journal-title":"Global Cancer Observatory: Cancer Today"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1038\/s41591-022-02109-2","volume":"28","author":"Guida F.","year":"2022","unstructured":"Guida F.; Kidman R.; Ferlay J.; Sch\u00fcz J.; Soerjomataram I.; Kithaka B.; Ginsburg O.; Mailhot Vega R.B.; Galukande M.; Parham G.; Vaccarella S.; Canfell K.; Ilbawi A.M.; Anderson B.O.; Bray F.; dos-Santos-Silva I.; McCormack V.; Global and regional estimates of orphans attributed to maternal cancer mortality in 2020. Nat Med  2022,28(12),2563-2572","journal-title":"Nat Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"710304","DOI":"10.3389\/fphar.2021.710304","volume":"12","author":"Ram\u00edrez M.H.","year":"2021","unstructured":"Ram\u00edrez M.H.; L\u00f3pez K.G.; Carranc\u00e1 A.; Polyphenols as antitumor agents targeting key players in cancer-driving signaling pathways. Front Pharmacol  2021,12,710304","journal-title":"Front Pharmacol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"7458","DOI":"10.1002\/fsn3.3699","volume":"11","author":"Golmohammadi M.","year":"2023","unstructured":"Golmohammadi M.; Zamanian M.Y.; Jalal S.M.; Noraldeen S.A.M.; Ram\u00edrez-Coronel A.A.; Oudaha K.H.; Obaid R.F.; Almulla A.F.; Bazmandegan G.; Kamiab Z.; A comprehensive review on Ellagic acid in breast cancer treatment: From cellular effects to molecular mechanisms of action. Food Sci Nutr  2023,11(12),7458-7468","journal-title":"Food Sci Nutr"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.2174\/1389202917666160803150639","volume":"18","author":"Guam\u00e1n-Ortiz L.","year":"2017","unstructured":"Guam\u00e1n-Ortiz L.; Orellana M.; Ratovitski E.; Natural compounds as modulators of non-apoptotic cell death in cancer cells. Curr Genomics  2017,18(2),132-155","journal-title":"Curr Genomics"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"e4071","DOI":"10.1002\/cbf.4071","volume":"42","author":"Zamanian M.Y.","year":"2024","unstructured":"Zamanian M.Y.; Golmohammadi M.; Yumashev A.; Hjazi A.; Toama M.A.; AbdRabou, M.A.; Gehlot, A.; Alwaily, E.R.; Shirsalimi, N.; Yadav, P.K.; Moriasi, G. Effects of metformin on cancers in experimental and clinical studies: Focusing on autophagy and AMPK\/mTOR signaling pathways. Cell Biochem Funct  2024,42(4),e4071","journal-title":"Cell Biochem Funct"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/biom10010047","volume":"10","author":"Khan T.","year":"2019","unstructured":"Khan T.; Anticancer plants: A review of the active phytochemicals, applications in animal models, and regulatory aspects. Biomolecules  2019,10(1),47","journal-title":"Biomolecules"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev-pharmtox-010818-021511","volume":"59","author":"Van Hasselt J.C.","year":"2019","unstructured":"Van Hasselt J.C.; Iyengar R.J.A.; Systems pharmacology: Defining the interactions of drug combinations. Annu Rev Pharmacol Toxicol  2019,59,21-40","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3390\/pharmaceutics11050208","volume":"11","author":"Vakil V.","year":"2019","unstructured":"Vakil V.; Trappe W.J.P.; Drug combinations: Mathematical modeling and networking methods. Pharmaceutics  2019,11(5),208","journal-title":"Pharmaceutics"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nrd2188","volume":"5","author":"Frantz S.J.N.","year":"2006","unstructured":"Frantz S.J.N.; The trouble with making combination drugs. Nat Rev Drug Discov  2006,5,881-882","journal-title":"Nat Rev Drug Discov"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ajps.2020.06.004","volume":"16","author":"Wang X.","year":"2021","unstructured":"Wang X.; Drug-drug cocrystals: Opportunities and challenges. Asian J Pharm Sci  2021,16(3),307-317","journal-title":"Asian J Pharm Sci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"780582","DOI":"10.3389\/fphar.2021.780582","volume":"12","author":"Kumar Bandaru R.","year":"2021","unstructured":"Kumar Bandaru R.; Rout S.R.; Kenguva G.; Gorain B.; Alhakamy N.A.; Kesharwani P.; Dandela R.; Recent advances in pharmaceutical cocrystals: From bench to market. Front Pharmacol  2021,12,780582","journal-title":"Front Pharmacol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3390\/cryst12101337","volume":"12","author":"Kara D.D.","year":"2022","unstructured":"Kara D.D.; Rathnanand M.; Cocrystals and drug\u2013drug cocrystals of anticancer drugs: A perception towards screening techniques, preparation, and enhancement of drug properties. Crystals  2022,12(10),1337","journal-title":"Crystals"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"483","DOI":"10.4103\/0250-474X.98981","volume":"73","author":"Singh V.","year":"2011","unstructured":"Singh V.; Chaudhary A.J.I.J.; A review on the taxonomy, ethnobotany, chemistry and pharmacology of Oroxylum indicum Vent. Indian J Pharm Sci  2011,73(5),483-490","journal-title":"Indian J Pharm Sci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.phytol.2019.05.003","volume":"32","author":"Wu B.L.","year":"2019","unstructured":"Wu B.L.; Wu Z-W.; Yang F.; Shen X-F.; Wang L.; Chen B.; Li F.; Wang M-K.; Flavonoids from the seeds of Oroxylum indicum and their anti-inflammatory and cytotoxic activities. Phytochem Lett  2019,32,66-69","journal-title":"Phytochem Lett"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.fitote.2011.04.006","volume":"82","author":"Yan R.","year":"2011","unstructured":"Yan R.; Cao Y.; Chen C.; Dai H.; Yu S.; Wei J.; Li H.; Yang B.; Antioxidant flavonoids from the seed of Oroxylum indicum. Fitoterapia  2011,82(6),841-848","journal-title":"Fitoterapia"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"5354215","DOI":"10.1155\/2020\/5354215","volume":"2020","author":"Chen J.","year":"2020","unstructured":"Chen J.; Chen J.; Lu J.; Systematic elucidation of the mechanism of Oroxylum indicum via network pharmacology. Evid Based Complement Alternat Med  2020,2020(1),5354215","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jep.2014.12.027","volume":"161","author":"Dinda B.","year":"2015","unstructured":"Dinda B.; SilSarma, I.; Dinda, M.; Rudrapaul, P. Oroxylum indicum (L.) Kurz, an important Asian traditional medicine: From traditional uses to scientific data for its commercial exploitation. J Ethnopharmacol  2015,161,255-278","journal-title":"J Ethnopharmacol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/ph15050559","volume":"15","author":"Singh A.R.","year":"2022","unstructured":"Singh A.R.; Singh S.A.; Singh T.D.; Singh N.T.; Machathoibi T.C.; Singh O.M.; Singh L.S.; Bioassay-guided isolation of 2-[p-(2-Carboxyhydrazino)phenoxy]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol from Oroxylum indicum and the investigation of its molecular mechanism action of apoptosis induction. Pharmaceuticals  2022,15(5),559","journal-title":"Pharmaceuticals"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1107\/S0108767307043930","volume":"64","author":"Sheldrick G.M.","year":"2008","unstructured":"Sheldrick G.M.; A short history of SHELX. Acta Crystallogr A  2008,64(1),112-122","journal-title":"Acta Crystallogr A"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3109\/10837450.2014.882937","volume":"20","author":"Renko\u011flu P.","year":"2015","unstructured":"Renko\u011flu P.; \u00c7elebier M.; Yegin A.B.; HPLC determination of olanzapine and carbamazepine in their nicotinamide cocrystals and investigation of the dissolution profiles of cocrystal tablet formulations. Pharm Dev Technol  2015,20(3),380-384","journal-title":"Pharm Dev Technol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.26355\/eurrev_202103_25253","volume":"25","author":"Raina R.","year":"2021","unstructured":"Raina R.; Afroze N.; Kedhari Sundaram M.; Haque S.; Bajbouj K.; Hamad M.; Hussain A.; Chrysin inhibits propagation of HeLa cells by attenuating cell survival and inducing apoptotic pathways. Eur Rev Med Pharmacol Sci  2021,25(5),2206-2220","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"41204","DOI":"10.1021\/acsomega.3c04443","volume":"8","author":"Raina R.","year":"2023","unstructured":"Raina R.; Hussain A.; Almutary A.G.; Haque S.; Raza T.; D\u2019Souza A.C.; Subramani S.; Sajeevan A.; Co-administration of chrysin and luteolin with cisplatin and topotecan exhibits a variable therapeutic value in human cancer cells, HeLa. ACS Omega  2023,8(44),41204-41213","journal-title":"ACS Omega"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"6097","DOI":"10.1016\/j.bmc.2004.09.013","volume":"12","author":"Zhang T.","year":"2004","unstructured":"Zhang T.; Chen X.; Qu L.; Wu J.; Cui R.; Zhao Y.; Chrysin and its phosphate ester inhibit cell proliferation and induce apoptosis in Hela cells. Bioorg Med Chem  2004,12(23),6097-6105","journal-title":"Bioorg Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.3390\/ijms11052188","volume":"11","author":"Khoo B.Y.","year":"2010","unstructured":"Khoo B.Y.; Chua S.L.; Balaram P.; Apoptotic effects of chrysin in human cancer cell lines. Int J Mol Sci  2010,11(5),2188-2199","journal-title":"Int J Mol Sci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1016\/j.sjbs.2022.03.011","volume":"29","author":"Pawar J.S.","year":"2022","unstructured":"Pawar J.S.; Mustafa S.; Ghosh I.; Chrysin and Capsaicin induces premature senescence and apoptosis via mitochondrial dysfunction and p53 elevation in Cervical cancer cells. Saudi J Biol Sci  2022,29(5),3838-3847","journal-title":"Saudi J Biol Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.tox.2008.12.011","volume":"257","author":"Li H.N.","year":"2009","unstructured":"Li H.N.; Nie F.F.; Liu W.; Dai Q.S.; Lu N.; Qi Q.; Li Z.Y.; You Q.D.; Guo Q.L.; Apoptosis induction of oroxylin A in human cervical cancer HeLa cell line in vitro and in vivo. Toxicology  2009,257(1-2),80-85","journal-title":"Toxicology"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10495-016-1316-4","volume":"22","author":"Kiraly G.","year":"2017","unstructured":"Kiraly G.; Simonyi A.S.; Turani M.; Micronucleus formation during chromatin condensation and under apoptotic conditions. Apoptosis  2017,22(2),207-219","journal-title":"Apoptosis"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0076-6879(00)22004-1","author":"Bossy-Wetzel E.","year":"2000","unstructured":"Bossy-Wetzel E.; Green D.R.; Detection of apoptosis by annexin V labeling. Methods in enzymology; Elsevier  2000,15-18","journal-title":"Methods in enzymology; Elsevier"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"Elmore S.","year":"2007","unstructured":"Elmore S.; Apoptosis: A review of programmed cell death. Toxicol Pathol  2007,35(4),495-516","journal-title":"Toxicol Pathol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3892\/etm.2020.8454","volume":"19","author":"Guo Y.J.","year":"2020","unstructured":"Guo Y.J.; Pan W.W.; Liu S.B.; Shen Z.F.; Xu Y.; Hu L.L.; ERK\/MAPK signalling pathway and tumorigenesis (Review). Exp Ther Med  2020,19(3),1997-2007","journal-title":"Exp Ther Med"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41580-020-0255-7","volume":"21","author":"Lavoie H.","year":"2020","unstructured":"Lavoie H.; Gagnon J.; Therrien M.; ERK signalling: A master regulator of cell behaviour, life and fate. Nat Rev Mol Cell Biol  2020,21(10),607-632","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"10792","DOI":"10.1074\/jbc.273.17.10792","volume":"273","author":"Berra E.","year":"1998","unstructured":"Berra E.; Diaz-Meco M.T.; Moscat J.; The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase\/Akt pathway. J Biol Chem  1998,273(17),10792-10797","journal-title":"J Biol Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1128\/MCB.17.8.4346","volume":"17","author":"Berra E.","year":"1997","unstructured":"Berra E.; Municio M.M.; Sanz L.; Frutos S.; Diaz-Meco M.T.; Moscat J.; Positioning atypical protein kinase C isoforms in the UV-induced apoptotic signaling cascade. Mol Cell Biol  1997,17(8),4346-4354","journal-title":"Mol Cell Biol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1126\/science.270.5240.1326","volume":"270","author":"Xia Z.","year":"1995","unstructured":"Xia Z.; Dickens M.; Raingeaud J.; Davis R.J.; Greenberg M.E.; Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science  1995,270(5240),1326-1331","journal-title":"Science"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"327","DOI":"10.21037\/atm.2020.02.107","volume":"8","author":"Yang C.","year":"2020","unstructured":"Yang C.; Luo J.; Luo X.; Jia W.; Fang Z.; Yi S.; Li L.; Morusin exerts anti-cancer activity in renal cell carcinoma by disturbing MAPK signaling pathways. Ann Transl Med  2020,8(6),327","journal-title":"Ann Transl Med"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1002\/jcb.26006","volume":"118","author":"Eid W.","year":"2017","unstructured":"Eid W.; Abdel-Rehim W.; Neferine enhances the antitumor effect of mitomycin\u2010C in hela cells through the activation of p38\u2010MAPK pathway. J Cell Biochem  2017,118(10),3472-3479","journal-title":"J Cell Biochem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"152973","DOI":"10.1016\/j.phymed.2019.152973","volume":"62","author":"Yao W.","year":"2019","unstructured":"Yao W.; Lin Z.; Wang G.; Li S.; Chen B.; Sui Y.; Huang J.; Liu Q.; Shi P.; Lin X.; Liu Q.; Yao H.; Delicaflavone induces apoptosis via mitochondrial pathway accompanying G2\/M cycle arrest and inhibition of MAPK signaling cascades in cervical cancer HeLa cells. Phytomedicine  2019,62,152973","journal-title":"Phytomedicine"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/cryst8020101","volume":"2","author":"Thakuria R.","year":"2018","unstructured":"Thakuria R.; Sarma B.J.C.; Drug-drug and drug-nutraceutical cocrystal\/salt as alternative medicine for combination therapy: A crystal engineering approach. Crystals  2018,2,101","journal-title":"Crystals"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.jconrel.2022.12.042","volume":"353","author":"Kumbhar P.","year":"2023","unstructured":"Kumbhar P.; Kolekar K.; Co-crystal nanoarchitectonics as an emerging strategy in attenuating cancer: Fundamentals and applications. J Control Release  2023,353,1150-1170","journal-title":"J Control Release"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.partic.2021.03.015","volume":"58","author":"Nascimento A.L.","year":"2021","unstructured":"Nascimento A.L.; Fernandes R.P.; Co-crystals of non-steroidal anti-inflammatory drugs (NSAIDs): Insight toward formation, methods, and drug enhancement. Particuology  2021,58,227-241","journal-title":"Particuology"}],"container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715206364530241128044041","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/237207\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715206364530241128044041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T14:21:58Z","timestamp":1745245318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/237207\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0118715206364530241128044041","relation":{},"ISSN":["1871-5206"],"issn-type":[{"value":"1871-5206","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-10-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}